| 2026-01-08 |
详情>>
内部人交易：
Pauwels Eric等共交易15笔
|
| 2025-11-04 |
详情>>
股本变动：
变动后总股本8028.83万股
|
| 2025-11-04 |
详情>>
业绩披露：
2025年三季报(累计)每股收益10.40美元,归母净利润8.18亿美元,同比去年增长374.91%
|
| 2025-11-04 |
财报披露：
美东时间 2025-11-04 盘后发布财报
|
| 2025-08-19 |
复牌提示：
2025-08-19 07:55:00 停牌，复牌日期 2025-08-19 08:30:00
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益10.22美元,归母净利润8.02亿美元,同比去年增长520.28%
|
| 2025-05-06 |
详情>>
业绩披露：
2025年一季报每股收益11.09美元,归母净利润8.67亿美元,同比去年增长1046.28%
|
| 2025-04-30 |
股东大会：
将于2025-06-17召开股东大会
会议内容 ▼▲
- 1.To elect the three Class III director nominees nominated by our Board of Directors and named in the proxy statement, each to serve for a term ending in 2028, or until his or her successor has been duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP, a registered public accounting firm, as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
3.To hold an advisory vote to approve named executive officer compensation;
4.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2025-02-27 |
详情>>
业绩披露：
2024年年报每股收益-4.73美元,归母净利润-3.63亿美元,同比去年增长42.02%
|
| 2025-02-27 |
详情>>
业绩披露：
2022年年报每股收益-7.79美元,归母净利润-5.59亿美元,同比去年增长-6.7%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-3.88美元,归母净利润-2.97亿美元,同比去年增长36.83%
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益-2.49美元,归母净利润-1.91亿美元,同比去年增长43.54%
|
| 2024-08-08 |
详情>>
业绩披露：
2023年中报每股收益-4.55美元,归母净利润-3.38亿美元,同比去年增长-21.17%
|
| 2024-04-26 |
股东大会：
将于2024-06-18召开股东大会
会议内容 ▼▲
- 1.To elect the four Class II director nominees nominated by our Board of Directors and named in the proxy statement, each to serve for a term ending in 2027, or until his or her successor has been duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP, a registered public accounting firm, as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
3.To hold an advisory vote to approve named executive officer compensation;
4.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2024-04-25 |
详情>>
业绩披露：
2024年一季报每股收益-1.2美元,归母净利润-9157.6万美元,同比去年增长34.10%
|
| 2024-02-29 |
详情>>
业绩披露：
2023年年报每股收益-8.37美元,归母净利润-6.27亿美元,同比去年增长-12.09%
|
| 2023-10-26 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-6.31美元,归母净利润-4.71亿美元,同比去年增长-21.3%
|
| 2023-04-26 |
股东大会：
将于2023-06-06召开股东大会
会议内容 ▼▲
- 1.To elect the four Class I director nominees nominated by our Board of Directors and named in the proxy statement, each to serve for a term ending in 2026, or until his or her successor has been duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP, a registered public accounting firm, as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
3.To hold an advisory vote to approve named executive officer compensation;
4.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2022-04-28 |
股东大会：
将于2022-06-08召开股东大会
会议内容 ▼▲
- 1.To elect the four Class III director nominees nominated by our Board of Directors and named in the proxy statement, each to serve for a term ending in 2025, or until his or her successor has been duly elected and qualified;
2.To approve the Company’s Amended and Restated 2013 Long-Term Incentive Plan;
3.To ratify the appointment of Ernst & Young LLP, a registered public accounting firm, as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
4.To hold an advisory vote to approve named executive officer compensation;
5.To hold an advisory vote on the frequency of the advisory vote to approve named executive officer compensation;
6.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-29 |
股东大会：
将于2021-06-08召开股东大会
会议内容 ▼▲
- 1.To elect the four Class II director nominees nominated by our Board of Directors and named in the proxy statement, each to serve for a term ending in 2024, or until his or her successor has been duly elected and qualified;
2.To approve an amendment to the Company’s Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 125,000,000 to 250,000,000;
3.To approve an amendment to the Company’s 2016 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for issuance under the plan from 1,000,000 to 2,000,000;
4.To ratify the appointment of Ernst & Young LLP, a registered public accounting firm, as our independent registered public accounting firm for the fiscal year ending December 31, 2021;
5.To hold an advisory vote to approve named executive officer compensation;
6.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2020-05-28 |
股东大会：
将于2020-06-10召开股东大会
会议内容 ▼▲
- 1.To elect the three Class I director nominees nominated by our Board of Directors and named in the proxy statement, each to serve for a term ending in 2023, or until his or her successor has been duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP, a registered public accounting firm, as our independent registered public accounting firm for the fiscal year ending December 31, 2020;
3.To hold an advisory vote to approve named executive officer compensation;
4.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2019-04-25 |
股东大会：
将于2019-06-12召开股东大会
会议内容 ▼▲
- 1.To elect the three Class III director nominees nominated by our Board of Directors and named in the proxy statement, each to serve for a term ending in 2022, or until his or her successor has been duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP, a registered public accounting firm, as our independent registered public accounting firm for the fiscal year ending December 31, 2019;
3.To hold an advisory vote to approve named executive officer compensation;
4.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2018-04-30 |
股东大会：
将于2018-06-13召开股东大会
会议内容 ▼▲
- 1.To elect the two Class II director nominees nominated by our Board of Directors and named in the proxy statement, each to serve for a term ending in 2021, or until his successor has been duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP, a registered public accounting firm, as our independent registered public accounting firm for the fiscal year ending December 31, 2018;
3.To hold an advisory vote to approve named executive officer compensation;
4.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2017-04-28 |
股东大会：
将于2017-06-09召开股东大会
会议内容 ▼▲
- 1.To elect the two Class I director nominees nominated by our Board of Directors and named in the proxy statement, each to serve for a term ending in 2020, or until his successor has been duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP, a registered public accounting firm, as our independent registered public accounting firm for the fiscal year ending December 31, 2017;
3.To hold an advisory vote to approve named executive officer compensation;
4.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2016-04-28 |
股东大会：
将于2016-06-10召开股东大会
会议内容 ▼▲
- 1. To elect the four Class III director nominees nominated by our Board of Directors and named in the proxy statement, each to serve for a term ending in 2019, or until his or her successor has been duly elected and qualified;
2. To ratify the appointment of Ernst & Young LLP, a registered public accounting firm, as our independent registered public accounting firm for the fiscal year ending December 31, 2016;
3. To hold an advisory vote to approve named executive officer compensation;
4. To hold an advisory vote on the frequency of the advisory vote to approve named executive officer compensation;
5. To approve the 2016 Employee Stock Purchase Plan;
6. To act upon a stockholder resolution concerning the adoption by the Board and submission to stockholders of a 'proxy access' bylaw, if properly presented at the Annual Meeting;
7. To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|